Labcorp Holdings Inc. (LH)
Runs the largest network of labs that test blood, drugs, and diseases for doctors and patients
$301.17+0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+15.2%
The outlook
LH is trading near the top of its 52-week range with analyst sentiment decidedly positive (Buy consensus from 17 analysts) and price comfortably above both short and long-term moving averages. The average analyst price target sits roughly 4% above the current level, though the stock's trailing P/E of 26.3 reflects a premium valuation relative to historical norms.
What’s behind the score
Analyst consensusBuy — 1.6 avg of 17 analysts
Price trendAbove its 50- & 200-day averages
52-week range99% of the way from its 52-week low to high
Price targetAvg target +4% vs current price
Analyst price target
~12-month · 17 analysts$312.35average target+3.7% vs now
Now $301.17
Low $270.00High $340.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
—
52-wk high
$301.79
52-wk low
$244.52
50-day avg
$269.44
200-day avg
$267.58
Trailing P/E
26.3